These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 46276)

  • 21. Experimental transmission of feline fibrosarcoma to cats and dogs.
    Gardner MB; Rongey RW; Arnstein P; Estes JD; Sarma P; Huebner RJ; Rickard CG
    Nature; 1970 May; 226(5248):807-9. PubMed ID: 5444620
    [No Abstract]   [Full Text] [Related]  

  • 22. Cell-mediated immunity to Friend virus-induced leukemia. III. Characteristics of secondary cell-mediated cytotoxic response.
    Ting CC; Kirchner H; Rodrigues D; Park JY; Herberman RB
    J Immunol; 1976 Jan; 116(1):244-52. PubMed ID: 54388
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oncogenicity of feline fibrosarcoma viruses in marmoset monkeys: pathologic, virologic, and immunologic findings.
    Wolfe LG; Smith RD; Hoekstra J; Marczynska B; Smith RK; McDonald R; Northrop RL; Deinhardt F
    J Natl Cancer Inst; 1972 Aug; 49(2):519-39. PubMed ID: 4116525
    [No Abstract]   [Full Text] [Related]  

  • 24. Effect of bacille Calmette-Guerin immunotherapy on feline sarcoma virus-induced neoplasms in the cat.
    Bachman D; Cockerell GL; de Noronha F; Rapp HJ
    Am J Vet Res; 1982 Mar; 43(3):475-80. PubMed ID: 6280529
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Specific depression of the antitumor cellular immune response with autologous tumor homogenate.
    Paranjpe MS; Boone CW
    Cancer Res; 1975 May; 35(5):1205-9. PubMed ID: 164281
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlation between changes in antitumor immune parameters and tumor growth in vivo in rats.
    Bansal SC; Sjögren HO
    Fed Proc; 1973 Feb; 32(2):165-72. PubMed ID: 4347409
    [No Abstract]   [Full Text] [Related]  

  • 27. Restoration of immune response by levamisole in B-77 virus induced tumor-bearing rats.
    Kalafut F; Kusenda J; Novotná L; Klobusická M
    Neoplasma; 1988; 35(4):369-78. PubMed ID: 2847064
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The activity of regional nodes in the evolution of immune responses to allogeneic and isogeneic tumors.
    Barna B; Deodhar SD
    Cancer Res; 1975 Apr; 35(4):920-6. PubMed ID: 1116149
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Passive transfer of systemic tumor immunity with cells generated in vitro by a secondary immune response to a syngeneic rat gross virus-induced lymphoma.
    Bernstein ID
    J Immunol; 1977 Jan; 118(1):122-8. PubMed ID: 830744
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of the antitumor activities of human tumor necrosis factor-alpha and the comparison with other cytokines: induction of tumor-specific immunity.
    Palladino MA; Shalaby MR; Kramer SM; Ferraiolo BL; Baughman RA; Deleo AB; Crase D; Marafino B; Aggarwal BB; Figari IS
    J Immunol; 1987 Jun; 138(11):4023-32. PubMed ID: 3295044
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The specificity of concomitant tumor immunity at large tumor volumes.
    Deckers PJ; Pardridge DH; Wang BS; Mannick JA
    Cancer Res; 1976 Oct; 36(10):3690-4. PubMed ID: 953994
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The nature of immunity to Snyder-Theilen fibrosarcoma virus induced tumors in cats.
    Johnson L; Pedersen NC; Theilen GH
    Vet Immunol Immunopathol; 1985 Jul; 9(3):283-300. PubMed ID: 2994282
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Attempted induction of sarcoma in a Cape Chacma baboon with the Snyder-Theilen feline sarcoma virus.
    Van der Riet Fde S; Kahn LB
    S Afr Med J; 1973 Jun; 47(22):943-4. PubMed ID: 4197095
    [No Abstract]   [Full Text] [Related]  

  • 34. Proceedings: Proposed mechanisms by which autochthonous neoplasms escape immune rejection.
    Coggin JH; Ambrose KR; Dierlam PJ; Anderson NG
    Cancer Res; 1974 Aug; 34(8):2092-101. PubMed ID: 4366506
    [No Abstract]   [Full Text] [Related]  

  • 35. Immunization against feline oncarnavirus disease using a killed tumor cell vaccine.
    Olsen RG; Hoover EA; Mathes LE; Heding L; Schaller JP
    Cancer Res; 1976 Oct; 36(10):3642-6. PubMed ID: 182360
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characteristics of immunity induced by neuraminidase-treated lymphosarcoma cells in C3H (MTV+) and C3H (MTV-) mice.
    Bekesi JG; Roboz JP; Holland JF
    Isr J Med Sci; 1976; 12(4-5):288-303. PubMed ID: 181351
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunosuppression of T lymphocyte function by fractionated serum from tumor-bearing mice.
    McMaster R; Buhler K; Whitney R; Levy JG
    J Immunol; 1977 Jan; 118(1):218-22. PubMed ID: 299757
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cell-mediated immunity to friend virus-induced leukemia. IV. In vitro generation of primary and secondary cell-mediated cytotoxic responses.
    Ting CC; Bonnard GD
    J Immunol; 1976 May; 116(5):1419-25. PubMed ID: 58034
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Specific enhancement of tumor growth and depression of cell-mediated immunity following sensitization to soluble tumor antigens.
    Rao VS; Bonavida B
    Cancer Res; 1976 Apr; 36(4):1384-91. PubMed ID: 56998
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development and inhibition of cytotoxic antibody against spontaneous murine breast cancer.
    Stolfi RL; Fugmann RA; Stolfi LM; Martin DS
    J Immunol; 1975 Jun; 114(6):1824-30. PubMed ID: 1127230
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.